Generic Name and Formulations:
Luliconazole 1%; cream.
Valeant Pharmaceuticals, Inc
Indications for LUZU:
Interdigital tinea pedis, t. cruris, and t. corporis caused by Trichophyton rubrum and Epidermophyton floccosum.
Adults and Children:
Apply to affected area and approximately 1 inch of the immediate surrounding area(s) once daily. T. corporis (≥2yrs): treat for 1 week. T. pedis (≥12yrs): treat for 2 weeks. T. cruris (≥12yrs): treat for 1 week.
Not for ophthalmic, oral, or intravaginal use. Pregnancy. Nursing mothers.
May inhibit CYP2C19 activity.
Application site reactions.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Autonomic Function May Have Directional Effect on Depression
- Predictors of Long-term Medication Adherence in Children With ADHD
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Substance Abuse and Primary Psychosis: A Closer Look